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Supplementary Figures 
 
Supplementary Figure 1: Quantile-Quantile (QQ) plot of the discovery phase meta-
analysis of RR-interval among the European-ancestry individuals 
 
The red line is the line Y = X. The lambda indicates the genomic inflation factor. P-
values are plotted on a –log10 scale. 
 
 
 
 
 
 
Supplementary Figure 2 
a: Comparison of the betas between the untransformed RR-interval meta-analysis 
and the inverse normalized RR-interval residuals (RR-INVN) meta-analysis 
 
Betas for RR interval (ms) are based on the meta-analysis of the 30 European-
ancestry cohorts (N = 104,452). The red regression line is based on a linear 
regression with outcome Beta(RR-INVN) and determinant Beta (RR-interval). The 
Pearson’s correlation coefficient is indicated. 
 
 
 
 
b: Comparison of the P-values between the untransformed RR-interval meta-analysis 
and the inverse normalized RR-interval residuals (RR-INVN) meta-analysis 
 
 
 
P-value results are based on the meta-analysis of the 30 European-ancestry cohorts 
(N = 104,452). The red regression line is based on a linear regression with outcome 
P-value (RR-INVN) and determinant P-value (RR-interval). The Pearson’s correlation 
coefficient is indicated. 
 
Supplementary Figure 3:  
a. Histogram showing the distribution of RR-interval phenotype in the 1958BC 
study 
 
The normal distribution with the same mean and standard deviation as the data is 
shown in blue, for RR interval (ms). 
 
 
 
 
 
 b. Quantile-Quantile (QQ) plot of RR-interval phenotype in the 1958BC study 
 
The ranked RR-intervals (in milliseconds) of the 1985BC study are plotted against a 
ranked standard normal distribution.  
 
 
 
 
 
Supplementary Figure 4 
a: Comparison of the betas between the RR-interval meta-analysis with and without 
beta-blocker users.  
 
The beta results plotted are for RR interval in milliseconds. The blue points indicate 
SNVs with P values below 0.05; Red points indicate SNVs with P values below 1 x 10-
5, according to P-values from the final primary EUR discovery meta-analysis. The 
reported correlation coefficient is based on the SNVs with P value below 0.05 from 
the final primary European discovery meta-analysis. The three red points in the top 
right corner were excluded from the meta-analysis results after quality control due 
to their large betas and standard errors. The results for the meta-analysis with beta-
blocker users included were taken from data from the same 17 cohorts as those with 
beta-blocker users excluded: 1958BC, AGES, ASCOT-UK, ASCOT-SC, BRIGHT, CHS, 
ERF, GODARTS, Generation Scotland, KORCULA, UHP, MGH, NEO, RS, SardiNIA, SHIP, 
YFS (N=48,347).  
  
 b: Comparison of the P-values between the RR-interval meta-analysis with and 
without beta-blocker users.  
 
 
 
The results for the meta-analysis with beta-blocker users included were taken from 
data from the same 17 cohorts as those with beta-blocker users excluded: 1958BC, 
AGES, ASCOT UK, ASCOT SC, BRIGHT, CHS, ERF, GODARTS, Generation Scotland, 
KORCULA, UHP, MGH, NEO, RS, SardiNIA, SHIP, YFS (N = 48,347) 
 Supplementary Figure 5: Locus Zoom plots for the five unreported novel loci 
 
Locus Zoom plots are provided for each of the five unreported validated novel loci, 
showing association results from the RR-interval discovery meta-analysis in 
Europeans (N = 104,452). These were created using the stand-alone locus zoom 
plotting software (http://locuszoom.sph.umich.edu/). The linkage disequilibrium (LD) 
r2 was user-supplied and calculated in PLINK software from Exome-chip data from a 
subset of available studies (ASCOT-UK, ASCOT-SC, BRIGHT and 1958BC). The red line 
indicates a P-value threshold of 1x10-5 corresponding to the lookup significance 
threshold and the blue line indicates a P-value threshold of 2x10-7 corresponding to 
exome-wide significance. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 6: Forest plots showing the associations of the five 
unreported novel loci within all European discovery cohorts and non-European 
studies 
 
 
For each locus, the forest plot shows (in order): the study-level results for each of 
the 30 European cohorts contributing to the discovery meta-analysis; the discovery 
meta-analysis results; the study-level results for each of the five African ancestry 
cohorts; the African-ancestry meta-analysis results; the ancestry-stratified results 
within the MESA study for Chinese-Americans and Hispanics. In the forest plot, 
study-level results are displayed in blue with effect estimate boxes proportional to 
the sample size, and the meta-analysis results are displayed with red diamonds. 
 N: sample size; EAF: Effect Allele Frequency; Beta: effect size of RR-interval in 
milliseconds; SE: standard error; P: P-value 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 7: Effect sizes of associated variants: Comparison between 
novel loci and previously reported loci 
 
 
 
The effect sizes in miliseconds for association of variants with RR Interval from the 
primary Exome RR discovery meta-analysis in Europeans are plotted on the y-axis, 
with minor allele frequency (MAF) plotted on the x-axis. The variants coloured in 
black, denoted as “known loci”, correspond to the 11 published HR variants with 
strong evidence of support in our data, from the 12 previously reported GWAS 
variants which are covered on the Exome chip. The variants coloured in red, denoted 
as “new loci”, correspond to the lead variants at all nine novel loci validated in our 
study. 
 
